Federal award (DEFINITIVE CONTRACT, fiscal year 2024)
Recipient: SPERO THERAPEUTICS, INC.
Awarding agency: Department of Health and Human Services / Office of Assistant Secretary for Preparedness and Response
Funding agency: Department of Health and Human Services / Office of Assistant Secretary for Preparedness and Response
Period of performance: 2018-07-12 to 2025-12-31
Current total value of award: $43372809
Description: THE PURPOSE OF THIS BILATERAL MODIFICATION P00018 IS TO: A) CHANGE CLIN 0002 OPTION 1?S COST SHARE PORTION TO INCREASE SPERO?S SHARE FROM $161,178.00 BY $96,236.00 TO $257,414.00 WITH THE GOVERNMENT SHARE REMAINING UNCHANGED. B) THIS CHANGE HEREBY